IRIS - Res&Arch Institutional Research Information System - Research & Archive

GRESELE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.027
AS - Asia 9.673
EU - Europa 9.630
SA - Sud America 1.634
AF - Africa 229
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 10
Totale 34.221
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.736
SG - Singapore 4.285
IE - Irlanda 1.691
UA - Ucraina 1.652
HK - Hong Kong 1.636
RU - Federazione Russa 1.431
IT - Italia 1.375
BR - Brasile 1.214
CN - Cina 1.168
VN - Vietnam 1.007
SE - Svezia 803
DE - Germania 707
FR - Francia 616
FI - Finlandia 510
GB - Regno Unito 306
KR - Corea 287
TR - Turchia 271
BD - Bangladesh 221
IN - India 179
AR - Argentina 145
CA - Canada 144
IQ - Iraq 93
PL - Polonia 81
MX - Messico 71
NL - Olanda 71
JP - Giappone 69
ZA - Sudafrica 67
CO - Colombia 61
UZ - Uzbekistan 60
AT - Austria 58
CH - Svizzera 58
ES - Italia 58
PK - Pakistan 57
VE - Venezuela 55
ID - Indonesia 50
EC - Ecuador 49
SA - Arabia Saudita 48
BE - Belgio 46
PH - Filippine 35
LB - Libano 34
MA - Marocco 33
CL - Cile 32
MY - Malesia 26
PY - Paraguay 26
CZ - Repubblica Ceca 23
LT - Lituania 23
EG - Egitto 21
TN - Tunisia 21
BO - Bolivia 20
GR - Grecia 20
JO - Giordania 20
KE - Kenya 20
RO - Romania 16
AE - Emirati Arabi Uniti 14
KZ - Kazakistan 14
UY - Uruguay 14
DZ - Algeria 13
EU - Europa 13
MK - Macedonia 13
AL - Albania 12
JM - Giamaica 12
PE - Perù 12
AZ - Azerbaigian 10
IL - Israele 10
IR - Iran 10
NI - Nicaragua 10
NP - Nepal 10
OM - Oman 10
RS - Serbia 10
CR - Costa Rica 9
PS - Palestinian Territory 9
BG - Bulgaria 8
TH - Thailandia 8
ET - Etiopia 7
HN - Honduras 7
HU - Ungheria 7
PA - Panama 7
PT - Portogallo 7
TT - Trinidad e Tobago 7
AU - Australia 5
BH - Bahrain 5
DO - Repubblica Dominicana 5
GT - Guatemala 5
LY - Libia 5
AO - Angola 4
CI - Costa d'Avorio 4
GA - Gabon 4
KW - Kuwait 4
SN - Senegal 4
SY - Repubblica araba siriana 4
TZ - Tanzania 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BB - Barbados 3
CU - Cuba 3
HR - Croazia 3
LK - Sri Lanka 3
ME - Montenegro 3
NO - Norvegia 3
PR - Porto Rico 3
Totale 34.150
Salva come PNG Salva come JPEG
Città #
Singapore 2.891
Chandler 1.785
Dublin 1.678
Hong Kong 1.632
San Jose 1.185
San Mateo 906
Jacksonville 902
Ashburn 762
Boardman 533
Santa Clara 503
Moscow 484
Dong Ket 467
Altamura 434
Medford 416
Princeton 415
Lauterbourg 390
Perugia 349
Lawrence 312
Wilmington 291
Seoul 267
Ann Arbor 265
Beijing 259
Des Moines 229
Andover 211
Izmir 193
Munich 192
Ho Chi Minh City 188
Los Angeles 182
The Dalles 170
New York 162
Saint Petersburg 139
Hanoi 119
São Paulo 103
Piscataway 102
Helsinki 96
Turku 80
Norwalk 76
Tokyo 66
Frankfurt am Main 64
Orem 62
Rome 59
Redmond 55
Dearborn 54
Shanghai 54
Woodbridge 52
London 51
Dallas 49
Denver 47
Houston 47
Brooklyn 46
San Paolo di Civitate 46
Brussels 45
Montreal 43
Rio de Janeiro 41
Johannesburg 40
Atlanta 39
Baghdad 39
Chicago 39
Warsaw 39
Nuremberg 38
Stockholm 34
Chennai 32
San Diego 32
Toronto 32
Da Nang 31
Tashkent 31
Amsterdam 29
Belo Horizonte 29
Phoenix 27
Poplar 27
Falkenstein 25
Milan 25
Brasília 24
Ankara 23
Columbus 23
Council Bluffs 23
Mexico City 23
Curitiba 22
Manchester 22
Porto Alegre 22
San Francisco 22
Boston 20
Den Haag 19
Campinas 18
Dhaka 18
Guayaquil 18
Haiphong 18
New Delhi 18
Ottawa 18
Amman 17
Hải Dương 17
Jeddah 17
Nairobi 17
Quito 17
Riyadh 17
Buffalo 16
Caracas 16
Falls Church 16
Guangzhou 16
Istanbul 16
Totale 21.370
Salva come PNG Salva come JPEG
Nome #
Fisiopatologia dell'emostasi 527
PIASTRINE TRASFETTATE CON MATERIALE GENETICO ESOGENO E MICROPARTICELLE DERIVATE DA DETTE PIASTRINE TRASFETTATE, METODO PER LA LORO PREPARAZIONE E LORO USI. 265
Activation of phospholipase A2 and B-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. 178
Activation of human platelet phospholipase A2 induced by phisiological agonist or fluoroaluminate: effec of inhibitors of protein kinases 177
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. 147
5-ASA-glutamate protects rats from inflammaory bowel disease induced by intracolonic administration of trinitrobenzensulfonic acid. 146
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study. 146
Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management 145
Impact of Chronic Antiplatelet Therapy prior to Hospitalization on Ischemic and Bleeding Events in Invasively Managed Patients with Acute Coronary Syndromes: The ACUITY Trial 143
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients 142
Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. 141
Beta 1-tubulin in human platelets: not simply a structural cell frame. 138
Reperfusion of cerebral artery thrombosis by the GPIb-VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs. 138
Albumin prevents TxB2 formation from thrombin-stimulated human platelets by sequestring the liberated arachidonic acid in the extracellular space 137
A novel congenital dysprothrombinemia leading to defective prothrombin maturation. 136
Misurazione del PAF (fattore attivante le piastrine) nella saliva umana; standardizzazione del metodo 136
Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients 134
[Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention]. 133
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 133
Abstract 15389: High On-Treatment Platelet Reactivity in Clopidogrel-Treated Patients Undergoing Elective Carotid Stenting: Correlation with Previous Cerebrovascular Events 131
Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation. No effect of aspirin intake. 128
Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. 126
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia. 125
Nitric oxide and its antithrombotic action on the cardiovascular system 124
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 123
Platelets are essential for leukocyte recruitment in allergic inflammation. 123
Guida alla terapia antitrombotica curata dalla Federazione Nazionale Centri per la Diagnosi della Trombosi e la Sorveglianza delle Terapie Antitrombotiche (FCSA) 122
Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction. 121
HIV type 1 infection, and not short-term HAART, indice endothelial dysfunction. 120
A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling 120
Effect of substituted stilbenes on platelet function 119
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 119
Comparative evaluation of the fully automated HemosIL®AcuStar ADAMTS13 activity assay vs. ELISA: Possible interference by autoantibodies different from anti ADAMTS-13 119
A new case of acquired Glanzmann's thrombasthenia: Diagnostic value of flow cytometry. 118
Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma 118
Activation of phospholipase A2 and ß-thromboglobulin release in human platelets stimulated with thrombin and fluoro aluminate 117
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 117
C-reactive protein induces expression of matrix metalloproteinase-9: A possible link between inflammation and plaque rupture. 116
Germline GATA2 variant disrupting endothelial eNOS cell function and angiogenesis can be restored by c-Jun/AP-1 upregulation 116
Allergen induces the migration of platelets to lung tissue in allergic asthma. 115
Diagnosis of platelet-type von Willebrand disease by flow cytometry. 114
A comparison of lupus anticoagulant-positive patients with clinical picture of antiphospholipid syndrome and those without. 114
Defective platelet beta-N-Acetyl hexosaminidase content and release in chronic myeloproliferative disorders 113
Dominant inheritance of a novel integrin beta3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families. 112
Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation 112
Acquired von Willebrand syndrome type 2A in a JAK2-positive essential thrombocythaemia-affected member of a large von Willebrand disease family with a novel autosomal dominant A1716P mutation. 112
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 112
RhoA signaling through platelet P2Y1 receptor controls leukocyte recruitment in allergic mice. 111
In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients. 111
Cloricromene inhibits G-Protein mediated activation of phospholipase A2 in human platelets 110
A novel nitric oxide-releasing statin derivative exerts and antiplatelet/antithrombotic activity and inhibits tissue factor expression. 110
AB0952 Intra-articular low molecular weight hyaluronate reduces platelet influx and matrix metalloproteinase-2 levels in synovial fluid of patients with knee osteoarthritis 110
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 109
Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia 109
Tardive gestosis: clinical observations. 108
The european hematology association roadmap for european hematology research: A consensus document 108
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 107
Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives. 107
Effect of cloricromene on intermittent claudication. A randomized double-blind, placebo controlled trial in patients treated with aspirin: effect on claudication distance and quality of life 107
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant. 106
Choline plasmalogen biosynthesis by transmethylation in human platelets 106
Anti-platelet therapy: phosphodiesterase inhibitors. 106
Mechanisms of thrombocytopenia in platelet-type von Willebrand disease 106
Effect of First Long-Term Training on Whole Blood Count and Blood Clotting Parameters in Thoroughbreds 106
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 105
Assessment of occlusion of the vascular access in patients on chronic hemodialysis: comparison of physical examination with continuous-wave doppler ultrasound. 105
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 104
Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis. 104
A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders 104
Anti-platelet treatments in cancer: Basic and clinical research 104
Down-regulation of fluoroaluminate-induced release of arachidonic acid by protein kinase C is calcium-dependent and not related to secretory phospholipase A2 103
Association of Neutrophil Activation, More Than Platelet Activation, with Thrombotic Complications in Coronavirus Disease 2019 103
The release of arachidonic acid (AA ) by human platelets stimulated by fluoroaluminate and low concetration of collagene potentiated by inhibitors of protein kinase C (PKC). 102
In vitro effect of anti-β2 glycoprotein I antibodies on P-selectin expression: a marker of platelet activation 102
A dichotomy in platelet activation: Evidence of different functional platelet responses to inflammatory versus haemostatic stimuli 102
Arterite temporale occulta: contributo casistico e revisione della letteratura 101
Heparin in the prophylaxis and treatment of venous thromboembolism and other thrombotic diseases. 101
Platelets contribute to the accumulation of matrix metalloproteinase type 2 in synovial fluid in osteoarthritis 101
Selective cytochrome c displacement by phosphate and Ca2+ in brain mitochondria 100
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 100
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 99
Acetylsalicylic acid, BM 13.177 and picotamide improve the survival of endotoxin-infused rabbits 99
Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data 99
ABO Blood Group and Inhibitor Risk in Severe Hemophilia A Patients: A Study from the Italian Association of Hemophilia Centers 99
Platelet thromboxane A2 receptor number and function in normal and in hypertensive pregnancy. 98
Apparent genotype-phenotype mismatch in a patient with MYH9-related disease: when the exception proves the rule. 98
Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH. 98
Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia. 98
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 98
Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events. 97
Gestational diabetes mellitus is associated with in vivo platelet activation and platelet hyperreactivity 96
MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. 96
Inherited disorders and gene regulation of platelet signal transduction: the picture is expanding. 96
Effect of nitric oxide-donating agents on human monocyte cyclooxygenase-2. 96
A novel variant Glanzmann thrombasthenia due to co-inheritance of a loss- and a gain-of-function mutation of ITGB3: evidence of a dominant effect of gain-of-function mutations. 96
[Occult temporal arteritis. Case reports and review of the literature]. 96
Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET 96
Peripheral arteriopathy: effects of cloricromene on claudication and quality of life, a randomized double blind,,placebo controlled trial in patients treated with aspirin 95
Differences between human platelets erythrocyte membranes.A spectroscopic study with particular refernce to IR and Laser Raman spectroscopy. 95
Effect of different plasma expanders on erythrocyte filterability 95
Totale 11.986
Salva come PNG Salva come JPEG
Categoria #
all - tutte 159.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.038
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021518 0 0 0 0 0 0 0 0 0 0 0 518
2021/20223.196 75 630 79 129 104 22 37 998 43 113 416 550
2022/20235.964 462 1.152 97 451 461 684 6 253 2.128 19 161 90
2023/20242.648 138 203 121 41 29 13 1.019 52 220 99 412 301
2024/20255.200 55 556 145 195 684 241 188 409 1.195 311 791 430
2025/202611.363 819 737 604 1.493 1.632 984 2.039 470 1.229 876 353 127
Totale 35.047